Evaluation of Intestinal Secretion of Antibodies and Auto-antibodies Associated With Crohn's Disease
NCT ID: NCT00769236
Last Updated: 2014-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2008-06-30
2010-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Histopathologic and Lymphocyte Subpopulations Evaluation of the Upper Gastrointestinal Tract of Crohn's Disease
NCT05874349
Evaluation of Therapeutic Strategy to Prevent Crohn's Disease Endoscopic poSToperatIve recurreNce Based on earlY Dosage of Faecal Calprotectin
NCT06972901
Postoperative REcurrence and DynamICs of T Cell Subsets in Crohn's Disease
NCT02770495
Abnormal Fecal Microbiota in Healthy Subjects at High Risk for Crohn's Disease
NCT02826330
Immunological Characteristics of Preclinical IBD
NCT05698745
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patients with crohn disease
Blood sampling and biopsy
Biopsy and blood : Research for various antibodies
2
Patients reached by hemorrhagic first side-colitis
Biopsy and blood sampling
Biopsy and blood : research for various antibodies
3
Patients controls
Biopsy and blood sampling
Blood and biopsy : research for various antibodies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood sampling and biopsy
Biopsy and blood : Research for various antibodies
Biopsy and blood sampling
Biopsy and blood : research for various antibodies
Biopsy and blood sampling
Blood and biopsy : research for various antibodies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients reached by hemorrhagic first side-colitis
Exclusion Criteria
* indefinite colitis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sophie Desplat-Jego, MD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique des Hopitaux de Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laboratoire d'Immunologie - Hopital de la Conception
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-05
Identifier Type: -
Identifier Source: secondary_id
2008-A00080-55
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.